ADVERSE DRUG REACTION REPORTING PRACTICES BY HEALTH CARE PROFESSIONALS OF KARACHI, PAKISTAN: A QUALITATIVE SURVEY

Sidra Zaheer; Andaleeb Komal; Ather Akhlaq

doi:10.46903/gjms/19.01.943

ADVERSE DRUG REACTION REPORTING PRACTICES BY HEALTH CARE PROFESSIONALS OF KARACHI, PAKISTAN: A QUALITATIVE SURVEY

Sidra Zaheer, Andaleeb Komal, Ather Akhlaq

Abstract

Background: The safety of medications is of utmost concern for public health. In developed countries, adverse drug reaction reporting systems are well established, but in low-income and middle-income countries such as Pakistan, these are under-developed and ignored. The objective of this qualitative survey was to explore the adverse drug reaction reporting practices by health care professionals of Karachi, Pakistan.

Materials & Methods: Fifteen health care professionals (HCPs), including physicians, nurses and pharmacists from public, semi-private and private tertiary care hospitals were selected using purposive and snowball sampling for semi-structured interviews. Interviews were digitally recorded, transcribed verbatim, and were analyzed using Thematic Analysis.

Results: The results showed that almost all HCPs have a good understanding of ADR, but did not know the procedures of ADR reporting to the Drug Regulatory Authority of Pakistan (DRAP). Usually, the ADR was manually reported, with few hospitals having an electronic ADR reporting system. Barriers to the ADR reporting included a large influx of illiterate patients, over-burdened staff, lack of financial and technological resources, and ineffective administration. Facilitator to ADR reporting was electronic ADR system.

Conclusion: These findings would help the policymakers and health administrators to revise existing policies and devise new ones for the adoption of adverse drugs reporting (ADR) systems in hospitals.

Keywords

Adverse Drug Reaction; Adverse Drug Reaction Reporting System; Pharmacovigilance; Healthcare; Health Care Professionals; Physicians, Pharmacists; Nurses; Pakistan.

Full Text:

PDF

References

Shakeel S, Iffat W, Anjum F, Bushra R, Ibrahim S, Shafiq S. Emerging need of pharmacovigilance: Perspectives of future pharmacist in Pakistan. Int J Pharm Teach Pract 2014;5(2):6.

Safety Report Updates | FDA [Internet]. [cited 2020 Sep 10]. Available from: https://www.fda.gov/science-research/pediatrics/safety-report-updates

Organization WH. Pharmacovigilance: ensuring the safe use of medicines 2004 [cited 2020 Sep 10]; Available from: https://apps.who.int/iris/handle/10665/68782

Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J 2018 May; 26(4):453-61. https://doi.org/10.1016/j.jsps.2018.02.014

Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Lond). 2016 Oct;16(5):481-5. https://doi.org/10.7861/clinmedicine.16-5-481

Smith FJ. Research methods in pharmacy practice. 1st ed. London: Pharmaceutical Press; 2002.

ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy. Am J Health Syst Pharm 1995 Feb 15;52(4):417-9. https://doi.org/10.1093/ajhp/52.4.417

Uppsala Monitoring Centre. WHO Collaborating Centre for International Drug Monitoring. Privacy policy [Internet]. [cited 2020 Sep 10]. Available from: https://www.who-umc.org/about-us/privacy-policy/

Uppsala Monitoring Centre. WHO Collaborating Centre for International Drug Monitoring. Members of the WHO Programme for International Drug Monitoring [Internet]. [cited 2020 Sep 5]. Available from: https://www.who-umc.org/global-pharmacovigilance/who-programme-for-international-drug-monitoring/who-programme-members/

DRAP 2019. Pakistan National Pharmacovigilance Guidelines (Draft). Islamabad, Pakistan: Drug Regulatory Authority of Pakistan [Internet]. [cited 2020 Sep 10]. Available from: https://dra.gov.pk/docs/Draft%20Pakistan%20National%20Pharmacovigigilance%20guidlines%204-9-2019.pdf

Atif M, Ahmad M, Saleem Q, Curley L, Qamar-uz-Zaman M, Babar ZUD. Pharmaceutical policy in Pakistan. In: Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer; 2017. p. 25-44. https://doi.org/10.1007/978-3-319-51673-8_3

WHO | Deadly medicines contamination in Pakistan [Internet]. WHO-2013. World Health Organization; 2013 [cited 2020 Sep 1]. Available from: https://www.who.int/features/2013/pakistan_medicine_safety/en/

Drug Regulatory Authority of Pakistan, Ministry of National Health Services, Regulations & Coordination, Islamabad [Internet]. Pharmacy Services Division 2020 [cited 2020 Sep 1]. Available from: http://dra.gov.pk/Home/PharmacyServicesDivision

Hussain R, Hassali MA, Hashmi F, Farooqui M. A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan. J Pharm Policy Pract 2018 Dec;11(1):16. https://doi.org/10.1186/s40545-018-0143-0

WHO-UMC. MED Vigilance E-Reporting System [Internet]. WHO-UMC 2020 [cited 2020 Aug 11]. Available from: https://primaryreporting.who-umc.org/Reporting/Reporter?OrganizationID=PK

Drug Regulatory Authority of Pakistan, Ministry of National Health Services, Regulations & Coordination, Islamabad [Internet]. DRAP 2020 [cited 2020 Aug 17]. Available from: https://www.dra.gov.pk/Home/DownloadsAllDocs#gsc.tab=0

Kiani A. Drug monitoring. Dawn 2019 Feb 24 [cited 2020 Sep 12]. Available from: https://www.dawn.com/news/1465733/drug-monitoring

ICIJ's global probe: Defective medical devices causing death, disability [Internet]. [cited 2020 Aug 12]. Available from: https://www.thenews.com.pk/print/398620-icij-s-global-probe-defective-medical-devices-causing-death-disability

Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case study approach. BMC Med Res Methodol 2011;11(1):1-9. https://doi.org/10.1186/1471-2288-11-100

Patton MQ. Qualitative evaluation and research methods. 2nd ed. Los Angeles: SAGE Publications; 1990.

Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health 2015 Sep;42(5):533-44. https://doi.org/10.1007/s10488-013-0528-y

Browne K. Snowball sampling: using social networks to research non-heterosexual women. Int J Soc Res Methodol 2005;8(1):47-60. https://doi.org/10.1080/1364557032000081663

Guest G, Bunce A, Johnson L. How many interviews are enough? an experiment with data saturation and variability. Field Methods 2006;18(1):59-82. https://doi.org/10.1177/1525822X05279903

Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82(4):581-629. https://doi.org/10.1111/j.0887-378X.2004.00325.x

Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000;320(7227):114-6. https://doi.org/10.1136/bmj.320.7227.114

Hashmi F, Khan SM, Qureshi S, Malik UR, Atif N, Saleem F. Assessment of knowledge, attitude and practices of healthcare professionals towards adverse drug reactions monitoring and reporting: a cross-sectional study in Lahore, Pakistan. Mod Care J 2020; 17(3);e104827. https://doi.org/10.5812/modernc.104827

Nisa ZU, Zafar A, Zafar F, Pezaro S, Sher F. Adverse drug reaction monitoring and reporting among physicians and pharmacists in Pakistan: a cross-sectional study. Current Drug Safety 2020;15(2):137-46. https://doi.org/10.2174/1574886315666200427120322

Hussain R, Hassali MA, Ur Rehman A, Muneswarao J, Atif M, Babar ZU. A qualitative evaluation of adverse drug reaction reporting system in Pakistan: findings from the nurses' perspective. Int J Environ Res Public Health 2020 Apr 27;17(9):3039. https://doi.org/10.3390/ijerph17093039

Stoynova V, Getov IN, Naseva EK, Lebanova HV, Grigorov EE. Physicians' knowledge and attitude towards adverse event reporting system and result to intervention-randomized nested trial among Bulgarian physicians. Med Glas (Zenica) 2013 Aug;10(2):365-72. PMID: 23892860.

Toklu HZ, Soyalan M, Gültekin O, Özpolat M, Aydın MD, Günay AC. The knowledge and attitude of the healthcare professionals towards pharmacovigilance and adverse drug reaction reporting in northern Cyprus. J Pharmacovigilance 2016;4:193. https://doi.org/10.4172/2329-6887.1000193

Aljadhey H, Mahmoud MA, Alshammari TM, Al-Dhaeefi M, Le Louet H, Perez-Gutthann S, et al. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia. Saudi Med J 2015;36(9):1097. https://doi.org/10.15537/smj.2015.9.12125

Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol 2009 Aug 11;9:14. https://doi.org/10.1186/1472-6904-9-14

Dupotey Varela NM, Oliveira DR de, Sedeño Argilagos C, Oliveros Castro K, Mosqueda Pérez E, Hidalgo Clavel Y, et al. What is the role of the pharmacists, physicians' and nurses' perspectives in community and hospital settings of Santiago de Cuba. Braz J Pharm Sci 2011 Dec;47(4):709-18. https://doi.org/10.1590/S1984-82502011000400007

Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol 2017 Feb;83(2):227-46. https://doi.org/10.1111/bcp.13098

DOI: https://doi.org/10.46903/gjms/19.01.943